Peijia Medical Limited (PEIJIA-B) has filed its Monthly Return for June 2026 with the Hong Kong Stock Exchange, confirming a stable equity structure and an uptick in outstanding employee share options.

The authorised share capital remains unchanged at 1.00 billion ordinary shares with a par value of USD 0.0001, equivalent to USD 100,000.

Issued shares held steady at 674.74 million, with no treasury shares on record. The company reconfirmed compliance with Main Board Rule 13.32B, maintaining at least 25% public float.

Option activity was confined to grants under the 2020 Share Option Scheme: • 2.33 million new options were granted. • 0 options were exercised; hence, no new shares were issued and no funds were raised. • 0 options were cancelled, while 0.19 million lapsed.

As a result, total outstanding options across all schemes increased to 33.46 million, representing a potential 4.96% dilution of the current issued share base if fully exercised. The 2020 Share Option Scheme still permits a further 54.29 million shares to be issued upon future grants.

No warrants, convertible securities, share repurchases, redemptions or other equity-linked instruments were reported during the month.

Overall, PEIJIA-B ended June 2026 with an unchanged share count and solid public float compliance, while modestly expanding its pool of outstanding employee share options.